Your browser doesn't support javascript.
loading
Separation of Activated T Cells Using Multidimensional Double Spiral (MDDS) Inertial Microfluidics for High-Efficiency CAR T Cell Manufacturing.
Jeon, Hyungkook; Perez, Caleb R; Kyung, Taeyoon; Birnbaum, Michael E; Han, Jongyoon.
Afiliación
  • Jeon H; Department of Manufacturing Systems and Design Engineering (MSDE), Seoul National University of Science and Technology (SEOULTECH), 232 Gongneung-ro, Nowon-gu, Seoul 01811, Republic of Korea.
  • Birnbaum ME; Singapore-MIT Alliance for Research and Technology (SMART) Centre, Critical Analytics for Manufacturing Personalized-Medicine (CAMP) IRG, 1 CREATE Way, No. 04-13/14 Enterprise Wing, 138602, Singapore.
  • Han J; Ragon Institute of Mass General, MIT, and Harvard, 400 Technology Square, Cambridge, Massachusetts 02139, United States.
Anal Chem ; 96(26): 10780-10790, 2024 07 02.
Article en En | MEDLINE | ID: mdl-38889002
ABSTRACT
This study introduces a T cell enrichment process, capitalizing on the size differences between activated and unactivated T cells to facilitate the isolation of activated, transducible T cells. By employing multidimensional double spiral (MDDS) inertial sorting, our approach aims to remove unactivated or not fully activated T cells post-activation, consequently enhancing the efficiency of chimeric antigen receptor (CAR) T cell manufacturing. Our findings reveal that incorporating a simple, label-free, and continuous MDDS sorting step yields a purer T cell population, exhibiting significantly enhanced viability and CAR-transducibility (with up to 85% removal of unactivated T cells and approximately 80% recovery of activated T cells); we found approximately 2-fold increase in CAR transduction efficiency for a specific sample, escalating from ∼10% to ∼20%, but this efficiency highly depends on the original T cell sample as MDDS sorting would be more effective for samples possessing a higher proportion of unactivated T cells. This new cell separation process could augment the efficiency, yield, and cost-effectiveness of CAR T cell manufacturing, potentially broadening the accessibility of this transformative therapy and contributing to improved patient outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T / Separación Celular / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Anal Chem Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T / Separación Celular / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Anal Chem Año: 2024 Tipo del documento: Article